Evidence map›Paper›PMID 28824369›Full record

ArticleFrontiers in neuroscience2017

Donepezil Does Not Enhance Perceptual Learning in Adults with Amblyopia: A Pilot Study.

Susana T L Chung, Roger W Li, Michael A Silver, Dennis M Levi

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01115283 nacompletednot on this map

Improving Spatial and Temporal Vision in Adult and Juvenile Amblyopia

TypeinterventionalSponsorUniversity of California, BerkeleyRan2015 to 2022Enrolled50ConditionsAmblyopiaArmsPerceptual learning, Video Games, Occlusion therapy
NCT03109314 phase4completednot on this map

The Effect of Donepezil on Perceptual Learning in Adult Amblyopia

TypeinterventionalSponsorDennis LeviRan2012 to 2018Enrolled20ConditionsAmblyopiaArmsDonepezil, Single-letter training, Uncrowd training
NCT07226141 phase1 / phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Valproate for the Treatment of Residual Amblyopia

TypeinterventionalSponsorBoston Children's HospitalRan2026 to 2027Enrolled28ConditionsAmblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic, Amblyopia StrabismicArmsValproate, Placebo, Patch
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Cholinergic modulation of sensory perception and plasticity.Neuroscience and biobehavioral reviews · 2023
    Review
  6. Comprehensive review of amblyopia: Types and management.Indian journal of ophthalmology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Rethinking amblyopia 2020.Vision research · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Susana T L ChungSchool of Optometry, Vision Science Graduate Group, Helen Wills Neuroscience Institute, University of California, BerkeleyBerkeley, CA, United States.
Roger W LiSchool of Optometry, Vision Science Graduate Group, Helen Wills Neuroscience Institute, University of California, BerkeleyBerkeley, CA, United States.
Michael A SilverSchool of Optometry, Vision Science Graduate Group, Helen Wills Neuroscience Institute, University of California, BerkeleyBerkeley, CA, United States.
Dennis M LeviSchool of Optometry, Vision Science Graduate Group, Helen Wills Neuroscience Institute, University of California, BerkeleyBerkeley, CA, United States.
University of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amblyopia is a developmental disorder that results in a wide range of visual deficits. One proven approach to recovering vision in adults with amblyopia is perceptual learning (PL). Recent evidence suggests that neuromodulators can enhance adult plasticity. In this pilot study, we asked whether donepezil, a cholinesterase inhibitor, enhances visual PL in adults with amblyopia. Nine adults with amblyopia were first trained on a low-contrast single-letter identification task while taking a daily dose (5 mg) of donepezil throughout training. Following 10,000 trials of training, participants showed improved contrast sensitivity for identifying single letters. However, the magnitude of improvement was no greater than, and the rate of improvement was slower than, that obtained in a previous study in which six adults with amblyopia were trained using an identical task and protocol but without donepezil (Chung et al., 2012). In addition, we measured transfer of learning effects to other tasks and found that for donepezil, the post-pre performance ratios in both a size-limited (acuity) and a spacing-limited (crowding) task were not significantly different from those found in the previous study without donepezil administration. After an interval of several weeks, six participants returned for a second course of training on identifying flanked (crowded) letters, again with concurrent donepezil administration. Although this task has previously been shown to be highly amenable to PL in adults with amblyopia (Chung et al., 2012; Hussain et al., 2012), only one observer in our study showed significant learning over 10,000 trials of training. Auxiliary experiments showed that the lack of a learning effect on this task during donepezil administration was not due to either the order of training of the two tasks or the use of a sequential training paradigm. Our results reveal that cholinergic enhancement with donepezil during training does not improve or speed up PL of single-letter identification in adults with amblyopia, and importantly, it may even halt learning and transfer related to a crowding task.

Indexed as

amblyopiacholinesterase inhibitorscontrast sensitivitydonepezil (aricept)perceptual learninguncrowding

Identifiers

PMID28824369
PMCPMC5545606
OpenAlexW2743991696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.